Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Inactivation of membrane tumor necrosis factor alpha by gingipains from Porphyromonas gingivalis.

Mezyk-Kopec R, Bzowska M, Potempa J, Bzowska M, Jura N, Sroka A, Black RA, Bereta J.

Infect Immun. 2005 Mar;73(3):1506-14.

3.

The biphasic virulence activities of gingipains: activation and inactivation of host proteins.

Imamura T, Travis J, Potempa J.

Curr Protein Pept Sci. 2003 Dec;4(6):443-50. Review.

PMID:
14683429
4.
5.

Porphyromonas gingivalis gingipains: the molecular teeth of a microbial vampire.

O-Brien-Simpson NM, Veith PD, Dashper SG, Reynolds EC.

Curr Protein Pept Sci. 2003 Dec;4(6):409-26. Review.

PMID:
14683427
6.
7.

The role of gingipains in the pathogenesis of periodontal disease.

Imamura T.

J Periodontol. 2003 Jan;74(1):111-8. Review.

PMID:
12593605
8.

Porphyromonas gingivalis-derived lysine gingipain enhances osteoclast differentiation induced by tumor necrosis factor-α and interleukin-1β but suppresses that by interleukin-17A: importance of proteolytic degradation of osteoprotegerin by lysine gingipain.

Akiyama T, Miyamoto Y, Yoshimura K, Yamada A, Takami M, Suzawa T, Hoshino M, Imamura T, Akiyama C, Yasuhara R, Mishima K, Maruyama T, Kohda C, Tanaka K, Potempa J, Yasuda H, Baba K, Kamijo R.

J Biol Chem. 2014 May 30;289(22):15621-30. doi: 10.1074/jbc.M113.520510. Epub 2014 Apr 22.

9.

Hydrolysis of epithelial junctional proteins by Porphyromonas gingivalis gingipains.

Katz J, Yang QB, Zhang P, Potempa J, Travis J, Michalek SM, Balkovetz DF.

Infect Immun. 2002 May;70(5):2512-8.

10.

Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity.

Lourbakos A, Yuan YP, Jenkins AL, Travis J, Andrade-Gordon P, Santulli R, Potempa J, Pike RN.

Blood. 2001 Jun 15;97(12):3790-7.

11.

Rapid and efficient inactivation of IL-6 gingipains, lysine- and arginine-specific proteinases from Porphyromonas gingivalis.

Banbula A, Bugno M, Kuster A, Heinrich PC, Travis J, Potempa J.

Biochem Biophys Res Commun. 1999 Aug 11;261(3):598-602.

PMID:
10441472
12.

Cleavage of the human C5A receptor by proteinases derived from Porphyromonas gingivalis: cleavage of leukocyte C5a receptor.

Jagels MA, Ember JA, Travis J, Potempa J, Pike R, Hugli TE.

Adv Exp Med Biol. 1996;389:155-64.

PMID:
8861006
13.
14.
15.

Inhibition of trypsin-like cysteine proteinases (gingipains) from Porphyromonas gingivalis by tetracycline and its analogues.

Imamura T, Matsushita K, Travis J, Potempa J.

Antimicrob Agents Chemother. 2001 Oct;45(10):2871-6.

16.

Role of gingipains R in the pathogenesis of Porphyromonas gingivalis-mediated periodontal disease.

Genco CA, Potempa J, Mikolajczyk-Pawlinska J, Travis J.

Clin Infect Dis. 1999 Mar;28(3):456-65. Review.

PMID:
10194062
17.

Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement system.

Popadiak K, Potempa J, Riesbeck K, Blom AM.

J Immunol. 2007 Jun 1;178(11):7242-50.

18.

Identification of a new membrane-associated protein that influences transport/maturation of gingipains and adhesins of Porphyromonas gingivalis.

Sato K, Sakai E, Veith PD, Shoji M, Kikuchi Y, Yukitake H, Ohara N, Naito M, Okamoto K, Reynolds EC, Nakayama K.

J Biol Chem. 2005 Mar 11;280(10):8668-77. Epub 2005 Jan 4.

19.

Dual regulation of interleukin-8 production in human oral epithelial cells upon stimulation with gingipains from Porphyromonas gingivalis.

Uehara A, Naito M, Imamura T, Potempa J, Travis J, Nakayama K, Takada H.

J Med Microbiol. 2008 Apr;57(Pt 4):500-7. doi: 10.1099/jmm.0.47679-0.

PMID:
18349372
20.

Supplemental Content

Support Center